Hematological Malignancies

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematological Malignancies Trial in Worldwide (Pembrolizumab/vibostolimab coformuation)

Recruiting
  • Hematological Malignancies
  • Pembrolizumab/vibostolimab coformuation
  • Duarte, California
  • +64 more
Jan 27, 2023

Hematological Malignancies Trial in Worldwide (Talquetamab)

Recruiting
  • Hematological Malignancies
  • Birmingham, Alabama
  • +82 more
Aug 11, 2022

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML) Trial in Worldwide (NiCord®

Active, not recruiting
  • Hematological Malignancies
  • +6 more
  • NiCord® (omidubicel)
  • Cord Blood Unit
  • Los Angeles, California
  • +51 more
Jan 7, 2021

Hematological Malignancies Trial in Haifa, Jerusalem (Allogeneic MPBC transplantation from matched related donor)

Unknown status
  • Hematological Malignancies
  • Allogeneic MPBC transplantation from matched related donor
  • Haifa, Israel
  • +1 more
Nov 24, 2019

GVHD, Hematological Malignancies Trial in Jerusalem (ApoCell)

Unknown status
  • Graft Versus Host Disease
  • Hematological Malignancies
  • ApoCell
  • Jerusalem, Israel
    Department of Bone Marrow Transplantation
Jun 10, 2015

Hematological Malignancies Trial in Worldwide (HSV-TK)

Completed
  • Hematological Malignancies
  • HSV-TK
  • Hannover, Germany
  • +7 more
May 29, 2014